Fisetin vs Metformin

Head-to-head comparison of Fisetin (3,3',4',7-Tetrahydroxyflavone) and Metformin (Metformin Hydrochloride) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyFisetinMetformin
CategoryAnti-AgingAnti-Aging
Full Name3,3',4',7-TetrahydroxyflavoneMetformin Hydrochloride
Molecular Weight286.24 Da165.63 Da
Half-Life3-8 hours4-8.7 hours
Amino AcidsN/AN/A
Typical Dose1000-2000 mg/day500-2000 mg/day
RouteOralOral
Purity≥98%≥98%
Studies Count1804000
Research StatusPre-clinicalClinical

Fisetin Benefits

  • ✓senolytic activity
  • ✓reduces inflammatory signaling
  • ✓supports mitochondrial function
  • ✓may improve healthspan

Metformin Benefits

  • ✓AMPK activation
  • ✓improved insulin sensitivity
  • ✓reduced oxidative stress
  • ✓population-level longevity signal

Fisetin Dosing

1000-2000 mg/day orally|1-2 days per month in senolytic-style studies|take with a fat-containing meal

Metformin Dosing

500-2000 mg/day oral|start low and titrate in trials|taken with meals

Fisetin Side Effects

  • ⚠GI upset
  • ⚠headache
  • ⚠possible blood-thinner interaction

Metformin Side Effects

  • ⚠gastrointestinal upset
  • ⚠vitamin B12 reduction
  • ⚠diarrhea
  • ⚠rare lactic acidosis

Research Overview

Fisetin

Preclinical studies show fisetin can selectively target senescent cells and reduce age-related inflammatory markers. Early human research exists, but definitive anti-aging outcomes in humans are still unproven.

Metformin

Metformin has extensive human data and remains a leading candidate in geroscience research. Observational and mechanistic studies suggest it may influence pathways tied to aging, though definitive anti-longevity proof in healthy humans is still lacking.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Fisetin stacks with:

QuercetinCoQ10Nicotinamide Riboside

Metformin stacks with:

RapamycinNMNSpermidine
senolyticpolyphenolantioxidanthealthspanAMPKinsulin-sensitivitygerosciencemetabolism